Skip to main content
Premium Trial:

Request an Annual Quote

Precision BioSciences, Agrivida Ink Feedstock Trait Genetic Modification Pact

NEW YORK (GenomeWeb News) – Precision BioSciences and Agrivida have struck an agreement to use Precision Bio's genetic modification technology to develop traits in corn that can improve animal nutrition for the dairy and beef industries.

The partners will use Precision Bio's Directed Nuclease Editor (DNE) technology, which enables production of genome-editing enyzmes that can insert, remove, modify, and regulate genes in mammalian and plant cells, Research Triangle Park, NC-based Precision said today.

Located in Medford, Mass., Agrivida develops products that incorporate regulated proteins that are engineered for specific applications, including biomass feedstock for animal nutrition, bio-based fuels and chemicals, and industrial enzymes.

"The opportunity for improving the nutritional characteristics of crops for the dairy and beef market segments is significant," Agrivida CEO Dan Meagher said in a statement. He added that Precision Bio's DNE technology has delivered a compositional modification that will help boost productivity of ruminant animals that eat plants expressing a trait they have already developed.

Financial and other terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.